NCT02097199 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Sponder M, Dangl D, Kampf S, Fritzer-Szekeres M, Strametz-Juranek J
Exercise increases serum endostatin levels in female and male patients with diabetes and controls. Cardiovasc Diabetol. 2014 Jan 6;13:6. doi: 10.1186/1475-2840-13-6.
Sponder M, Fritzer-Szekeres M, Marculescu R, Litschauer B, Strametz-Juranek J
Physical inactivity increases endostatin and osteopontin in patients with coronary artery disease. Heart Vessels. 2015 Dec 11. [Epub ahead of print]
Sponder M, Sepiol K, Lankisch S, Priglinger M, Kampf S, Litschauer B, Fritzer-Szekeres M, Strametz-Juranek J
Endostatin and physical exercise in young female and male athletes and controls. Int J Sports Med. 2014 Dec;35(13):1138-42. doi: 10.1055/s-0034-1375692. Epub 2014 Jul 10.

Influence of Physical Activity on Promising Atherosclerosis Biomarkers

Clinical trial NCT02097199 - References